• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Mini-pool screening by nucleic acid testing for hepatitis B virus, hepatitis C virus, and HIV: preliminary results.

作者信息

Cardoso M S, Koerner K, Kubanek B

机构信息

German Red Cross Blood Transfusion Service of Baden-Württemberg, Germany.

出版信息

Transfusion. 1998 Oct;38(10):905-7. doi: 10.1046/j.1537-2995.1998.381098440853.x.

DOI:10.1046/j.1537-2995.1998.381098440853.x
PMID:9767739
Abstract

BACKGROUND

The purpose of this study was to evaluate the feasibility of nucleic acid testing (NAT) of mini-pools as a blood donation screening test.

STUDY DESIGN AND METHODS

The stepwise implementation of NAT of mini-pools began in January 1997. Since March 1997, all blood donations collected by the German Red Cross Blood Transfusion Service of Baden-Württemberg were tested for hepatitis B virus (HBV), hepatitis C virus (HCV), and HIV nucleic acids. An extra barcoded serum sample is collected from each blood donor for NAT-based screening, which is performed only on hepatitis B surface antigen-, anti-HCV-, anti-HIV-, and anti-Treponema pallidum-seronegative donations. Samples are pooled to a maximum of 96. Positive results are resolved through intersecting subpools (a chessboard design). NAT-based screening does not include a virus concentration step before nucleic acid extraction.

RESULTS

By the end of October 1997, 331, 783 donations in 3,779 pools had been screened. As yet, no viremic but seronegative blood donor has been found for the three markers.

CONCLUSION

It is feasible to incorporate NAT-based screening of mini-pools into the routine virus diagnostics of a large blood transfusion service. It remains to be determined whether screening blood donations by NAT will indeed increase the safety of blood supply.

摘要

相似文献

1
Mini-pool screening by nucleic acid testing for hepatitis B virus, hepatitis C virus, and HIV: preliminary results.
Transfusion. 1998 Oct;38(10):905-7. doi: 10.1046/j.1537-2995.1998.381098440853.x.
2
Nationwide nucleic acid amplification testing of hepatitis B virus, hepatitis C virus and human immunodeficiency virus type 1 for blood transfusion and follow-up study of nucleic acid amplification positive donors.全国范围内针对输血进行的乙型肝炎病毒、丙型肝炎病毒和1型人类免疫缺陷病毒核酸扩增检测以及核酸扩增阳性献血者的随访研究。
Jpn J Infect Dis. 2000 Jun;53(3):116-23.
3
Two HBV DNA+/HBsAg- blood donors identified by HBV NAT in Shenzhen, China.在中国深圳,通过乙肝病毒核酸检测(HBV NAT)鉴定出两名乙肝病毒脱氧核糖核酸(HBV DNA)阳性/乙肝表面抗原(HBsAg)阴性的献血者。
Transfus Apher Sci. 2009 Aug;41(1):3-7. doi: 10.1016/j.transci.2009.05.001. Epub 2009 May 31.
4
A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus.台湾地区采用核酸扩增技术筛查献血者的一项初步研究:检测隐匿性乙型肝炎病毒感染并缩短丙型肝炎病毒的血清学窗口期
Transfusion. 2008 Jun;48(6):1198-206. doi: 10.1111/j.1537-2995.2008.01672.x. Epub 2008 Apr 14.
5
High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan.在日本,使用特异性和灵敏性兼具的多重试剂通过核酸扩增检测对1600万血清学阴性献血者进行乙型肝炎病毒、丙型肝炎病毒和1型人类免疫缺陷病毒的高通量筛查。
J Virol Methods. 2003 Sep;112(1-2):145-51. doi: 10.1016/s0166-0934(03)00215-5.
6
Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus.德国红十字会献血服务机构核酸检测经验:超过3000万次人类免疫缺陷病毒1型、丙型肝炎病毒和乙型肝炎病毒献血筛查结果
Transfusion. 2008 Aug;48(8):1558-66. doi: 10.1111/j.1537-2995.2008.01718.x. Epub 2008 May 6.
7
Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.个体捐赠核酸检测对南非输血传播人类免疫缺陷病毒、乙型肝炎病毒和丙型肝炎病毒风险的影响。
Transfusion. 2009 Jun;49(6):1115-25. doi: 10.1111/j.1537-2995.2009.02110.x. Epub 2009 Feb 27.
8
Effect of viral nucleic acid testing on contamination frequency of manufacturing plasma pools.病毒核酸检测对制备血浆混合液污染频率的影响。
Transfusion. 2008 May;48(5):822-6. doi: 10.1111/j.1537-2995.2007.01612.x. Epub 2008 Jan 15.
9
The impact of nucleic acid testing to detect human immunodeficiency virus, hepatitis C virus, and hepatitis B virus yields from a single blood center in China with 10-years review.中国某单一血站 10 年回顾性研究核酸检测对人免疫缺陷病毒、丙型肝炎病毒和乙型肝炎病毒检测的影响。
BMC Infect Dis. 2022 Mar 23;22(1):279. doi: 10.1186/s12879-022-07279-5.
10
The Brazilian experience of nucleic acid testing to detect human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in blood donors.巴西在献血者中进行核酸检测以检测人类免疫缺陷病毒、丙型肝炎病毒和乙型肝炎病毒感染的经验。
Transfusion. 2018 Apr;58(4):862-870. doi: 10.1111/trf.14478. Epub 2018 Jan 30.

引用本文的文献

1
A proactive/reactive mass screening approach with uncertain symptomatic cases.主动/被动病例筛查方法,伴有不确定症状病例。
PLoS Comput Biol. 2024 Aug 14;20(8):e1012308. doi: 10.1371/journal.pcbi.1012308. eCollection 2024 Aug.
2
Development and validation of cost-effective SYBR Green-based RT-qPCR and its evaluation in a sample pooling strategy for detecting SARS-CoV-2 infection in the Indonesian setting.开发和验证具有成本效益的 SYBR Green 实时 RT-qPCR,并在印度尼西亚的样本混合策略中评估其检测 SARS-CoV-2 感染的效果。
Sci Rep. 2024 Jan 20;14(1):1817. doi: 10.1038/s41598-024-52250-w.
3
Pooling samples to increase testing capacity with Xpert Xpress SARS-CoV-2 during the Covid-19 pandemic in Lao People's Democratic Republic.
在老挝人民民主共和国 COVID-19 大流行期间,使用 Xpert Xpress SARS-CoV-2 进行合并样本以增加检测能力。
PLoS One. 2022 Sep 29;17(9):e0275294. doi: 10.1371/journal.pone.0275294. eCollection 2022.
4
Evaluation of SARS-CoV-2 genome detection by real-time PCR assay using pooled specimens.使用混合样本通过实时聚合酶链反应检测严重急性呼吸综合征冠状病毒2基因组的评估。
Future Virol. 2022 Apr. doi: 10.2217/fvl-2021-0014. Epub 2022 May 9.
5
Group testing can improve the cost-efficiency of prospective-retrospective biomarker studies.群组检测可以提高前瞻性-回顾性生物标志物研究的成本效益。
BMC Med Res Methodol. 2021 Mar 19;21(1):55. doi: 10.1186/s12874-021-01239-4.
6
Active Surveillance of Asymptomatic, Presymptomatic, and Oligosymptomatic SARS-CoV-2-Infected Individuals in Communities Inhabiting Closed or Semi-closed Institutions.对居住在封闭或半封闭机构中的社区内无症状、症状前和轻症新型冠状病毒感染者进行主动监测。
Front Med (Lausanne). 2021 Feb 4;8:640688. doi: 10.3389/fmed.2021.640688. eCollection 2021.
7
Pooling RT-qPCR testing for SARS-CoV-2 in 1000 individuals of healthy and infection-suspected patients.对 1000 名健康和疑似感染患者进行 SARS-CoV-2 的 RT-qPCR 检测。
Sci Rep. 2020 Nov 3;10(1):18899. doi: 10.1038/s41598-020-76043-z.
8
Cohort PCR Testing: A Strategic Method for Rapid SARS-CoV-2 Screening.队列聚合酶链反应检测:一种快速筛查严重急性呼吸综合征冠状病毒2的策略性方法。
Am J Clin Pathol. 2020 Jul 7;154(2):278-279. doi: 10.1093/ajcp/aqaa092.
9
History and Future of Nucleic Acid Amplification Technology Blood Donor Testing.核酸扩增技术用于献血者检测的历史与未来
Transfus Med Hemother. 2019 Apr;46(2):67-75. doi: 10.1159/000496749. Epub 2019 Feb 5.
10
A general framework for the regression analysis of pooled biomarker assessments.汇总生物标志物评估的回归分析通用框架。
Stat Med. 2017 Jul 10;36(15):2363-2377. doi: 10.1002/sim.7291. Epub 2017 Mar 28.